In a new study, scientists at the Max Planck Institute for Evolutionary Anthropology in Leipzig analyzed the impact of more ...

Large-scale drug atlas uncovers new genome editing modulators and potential therapeutic strategies for DNA repair-deficient cancers ...

Because it requires so little to produce, the new strain could help bring more flavorful, environmentally friendly meat ...

Epithelial ovarian cancer (EOC) is an aggressive malignancy with limited therapeutic options. Poly(ADP-ribose) polymerase inhibitors (PARPi) have ...

Epithelial ovarian cancer (EOC) is an aggressive malignancy with limited therapeutic options. Poly(ADP-ribose) polymerase ...

The gene therapies for cardiomyopathies market is poised for strong growth as advancements in genomic medicine accelerate the ...

Texas Sen. John Cornyn sounded the alarm that a biotech startup firm that has raised some $30 million to study diseases in embryos is working on gene-editing techniques for humans at their ...

Discover top biotech companies for 2026, featuring emerging stars and leaders set for major clinical and regulatory ...

We're living in a moment where science fiction is becoming medical reality. Imagine a world where doctors can simply rewrite ...

Neurons can rapidly rebalance their communication using a structural signal rather than electrical activity, overturning long-held assumptions about how synapses maintain stability.

Mutations in the ASPM gene are the most common cause of primary hereditary microcephaly in humans, a condition characterized ...

Quantum-Si Incorporated ("Quantum-Si," "QSI" or the "Company"), a proteomics technology company redefining protein analysis through single-molecule detection, today announced that the Compensation ...